DoP asks NPPA to review prices fixed for Eli Lilly’s insulin
However, the NPPA asked the company to stick to the insulin ceiling price it had fixed earlier, after the review of the case. Eli Lilly has challenged fixing the prices in respect of five different imported formulations of injection Insulin Lispro (Humalog) through an order dated July 19, 2012.
DoP asks NPPA to reconsider retail price fixation on Abbott’s
The DoP took up the matter and examined the argument from both the sides, before arriving at a decision to remand the review petition to the NPPA. Abbott, in its review application said that the NPPA fixed the retail price for the formulation based on recommendations of the Multi Disciplinary Committee (MDC) of Experts, using the average of
DoP asks NPPA to review, verify Bharat Serum and Vaccine's
The Department of Pharmaceuticals (DoP) has issued an order disposing the review application of Bharat Serum and Vaccine (BSVL) to the National Pharmaceutical Pricing Authority (NPPA) instructing to verify the applicability of GST factor by cross-checking the documents submitted by BSVL pertaining to the formulation Human Normal Immunoglobulin.
DoP asks NPPA to review, verify Bharat Serum and Vaccine’s
The Department of Pharmaceuticals (DoP) has issued an order disposing the review application of Bharat Serum and Vaccine (BSVL) to the Na Products Suppliers
DoP junks Skymap Pharma review plea against NPPA
New Delhi: In a major setback to Skymap Pharmaceuticals Limited, the Department of Pharmaceuticals (DoP) has rejected the review application filed by the drugmaker against a notification issued by the National Pharmaceutical Pricing Authority (NPPA) for fixing the retail price of Fluconazole Tablets 300mg.
